Dr. Mark Gordon

Yeah, this is recent.

Yeah, this is recent.

Yeah, this is recent.

Well, fake beta amyloid data. See, they've been relying on beta amyloid as being the focus. And what they're finding is the treatment that addresses beta amyloid, the antibody against beta amyloid, people are still getting progression of the disease.

Well, fake beta amyloid data. See, they've been relying on beta amyloid as being the focus. And what they're finding is the treatment that addresses beta amyloid, the antibody against beta amyloid, people are still getting progression of the disease.

Well, fake beta amyloid data. See, they've been relying on beta amyloid as being the focus. And what they're finding is the treatment that addresses beta amyloid, the antibody against beta amyloid, people are still getting progression of the disease.

Well, you know that in – there are papers that have been written about reproducibility. Reproducibility is where a researcher does a paper, makes a claim about the results of the science, and then people look at that and they want to go and reproduce it. To prove it, they found that 70% of them can't be reproduced.

Well, you know that in – there are papers that have been written about reproducibility. Reproducibility is where a researcher does a paper, makes a claim about the results of the science, and then people look at that and they want to go and reproduce it. To prove it, they found that 70% of them can't be reproduced.

Well, you know that in – there are papers that have been written about reproducibility. Reproducibility is where a researcher does a paper, makes a claim about the results of the science, and then people look at that and they want to go and reproduce it. To prove it, they found that 70% of them can't be reproduced.

And when you looked at the actual scientists who did the original work, goes back and tries to reproduce it, 7% failure rate. So there are major publications that have talked about this reproducibility error. I mean, you can go on to Google Scholar or else into Google and look at reproducibility.

And when you looked at the actual scientists who did the original work, goes back and tries to reproduce it, 7% failure rate. So there are major publications that have talked about this reproducibility error. I mean, you can go on to Google Scholar or else into Google and look at reproducibility.

And when you looked at the actual scientists who did the original work, goes back and tries to reproduce it, 7% failure rate. So there are major publications that have talked about this reproducibility error. I mean, you can go on to Google Scholar or else into Google and look at reproducibility.

Okay, so it seems like the fact that he was reusing the same images, stating that they were new images, so he was stacking the deck in his favor. Right. Because he had a point to make. God, that's so gross. $2.6 billion. Jeez. That's what the budget was. That's the National Institute of Health, yeah.

Okay, so it seems like the fact that he was reusing the same images, stating that they were new images, so he was stacking the deck in his favor. Right. Because he had a point to make. God, that's so gross. $2.6 billion. Jeez. That's what the budget was. That's the National Institute of Health, yeah.

Okay, so it seems like the fact that he was reusing the same images, stating that they were new images, so he was stacking the deck in his favor. Right. Because he had a point to make. God, that's so gross. $2.6 billion. Jeez. That's what the budget was. That's the National Institute of Health, yeah.

That's the motto. If they don't publish and have a positive finding, they're not going to get funding for the next project that they have.

That's the motto. If they don't publish and have a positive finding, they're not going to get funding for the next project that they have.

That's the motto. If they don't publish and have a positive finding, they're not going to get funding for the next project that they have.

Yeah, the editors of the journal that he's presenting it to.

Yeah, the editors of the journal that he's presenting it to.